These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 26438628)
21. In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice. Watanabe A; Mayumi K; Nishimura K; Osaki H Biopharm Drug Dispos; 2016 Sep; 37(6):373-8. PubMed ID: 27379984 [TBL] [Abstract][Full Text] [Related]
22. In Vitro and In Vivo Correlation of Hepatic Fraction of Metabolism by P450 in Dogs. Zhou X; Hui YH; Hudson L; Katyayan KK; Mohutsky MA; Hao J; Schober DA; Hembre EJ J Pharm Sci; 2019 Feb; 108(2):1017-1026. PubMed ID: 30244007 [TBL] [Abstract][Full Text] [Related]
23. Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator? Linder CD; Renaud NA; Hutzler JM Drug Metab Dispos; 2009 Jan; 37(1):10-3. PubMed ID: 18936109 [TBL] [Abstract][Full Text] [Related]
24. In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). A tool for biochemical toxicology. Mico BA; Federowicz DA; Ripple MG; Kerns W Biochem Pharmacol; 1988 Jul; 37(13):2515-9. PubMed ID: 3390214 [TBL] [Abstract][Full Text] [Related]
25. Case Study 9: Probe-Dependent Binding Explains Lack of CYP2C9 Inactivation by 1-Aminobenzotriazole (ABT). Sodhi JK; Halladay JS Methods Mol Biol; 2021; 2342():765-779. PubMed ID: 34272716 [TBL] [Abstract][Full Text] [Related]
26. Application of Osmotic Pumps for Sustained Release of 1-Aminobenzotriazole and Inhibition of Cytochrome P450 Enzymes in Mice: Model Comparison with the Hepatic P450 Reductase Null Mouse. Stringer RA; Ferreira S; Rose J; Ronseaux S Drug Metab Dispos; 2016 Aug; 44(8):1213-6. PubMed ID: 27271368 [TBL] [Abstract][Full Text] [Related]
27. Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices. Ly VT; Brock B Chem Biol Interact; 2011 Sep; 193(2):109-18. PubMed ID: 21741958 [TBL] [Abstract][Full Text] [Related]
28. The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity. Carcillo JA; Korzekwa KR; Jones GS; Parise RA; Gillespie DG; Whalen MJ; Kochanek PM; Branch RA; Kost CK Res Commun Mol Pathol Pharmacol; 1998 Oct; 102(1):57-68. PubMed ID: 9920346 [TBL] [Abstract][Full Text] [Related]
29. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
30. Inactivation of rabbit pulmonary cytochrome P-450 in microsomes and isolated perfused lungs by the suicide substrate 1-aminobenzotriazole. Mathews JM; Dostal LA; Bend JR J Pharmacol Exp Ther; 1985 Oct; 235(1):186-90. PubMed ID: 4045721 [TBL] [Abstract][Full Text] [Related]
31. Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling. Balani SK; Li P; Nguyen J; Cardoza K; Zeng H; Mu DX; Wu JT; Gan LS; Lee FW Drug Metab Dispos; 2004 Oct; 32(10):1092-5. PubMed ID: 15217988 [TBL] [Abstract][Full Text] [Related]
32. Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in rats. Tang W; Stearns RA; Chen Q; Bleasby K; Teffera Y; Colletti A; Hafey M; Evers R; Dean DC; Magriotis PA; Lanza TJ; Lin LS; Hagmann WK; Baillie TA Xenobiotica; 2008 Feb; 38(2):223-37. PubMed ID: 18197560 [TBL] [Abstract][Full Text] [Related]
33. Modulation of Cytochrome P450 Activity by 18β-Glycyrrhetic Acid and its Consequence on Buspirone Pharmacokinetics in Rats. Kim SB; Cho HJ; Kim YS; Kim DD; Yoon IS Phytother Res; 2015 Aug; 29(8):1188-94. PubMed ID: 26010440 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of metoprolol in the rat in vitro and in vivo. Arfwidsson A; Borg KO; Hoffmann KJ; Skånberg I Xenobiotica; 1976 Nov; 6(11):691-711. PubMed ID: 997586 [TBL] [Abstract][Full Text] [Related]
35. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms. Shayeganpour A; El-Kadi AO; Brocks DR Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463 [TBL] [Abstract][Full Text] [Related]
36. In vitro metabolism and inductive or inhibitive effect of DL111 on rat cytochrome P4501A enzyme. Hu YZ; Yao TW Chem Biol Interact; 2004 Mar; 147(2):109-17. PubMed ID: 15013813 [TBL] [Abstract][Full Text] [Related]
37. Alterations in the cardiopulmonary effects and pharmacokinetics of a bisphosphonate drug by a cytochrome P-450 inhibitor in conscious rats. Leong BK; Sabaitis CP; Rop DA; Jeffrey P; Parker TJ; Burton NK; Petry TW; Jolly RA; Cooper MM J Appl Toxicol; 1997; 17(5):279-88. PubMed ID: 9339740 [TBL] [Abstract][Full Text] [Related]
38. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs. Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473 [TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of pharmacokinetic profiles of verapamil and drug-drug interactions induced by a CYP inhibitor using a stable isotope-labeled compound. Kataoka M; Kojima C; Ueda K; Minami K; Higashino H; Sakuma S; Togashi K; Mutaguchi K; Yamashita S Drug Metab Pharmacokinet; 2016 Dec; 31(6):405-410. PubMed ID: 27876352 [TBL] [Abstract][Full Text] [Related]
40. N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P-450 in vivo. Knickle LC; Philpot RM; Bend JR J Pharmacol Exp Ther; 1994 Jul; 270(1):377-85. PubMed ID: 8035335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]